BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25163211)

  • 1. Probiotics: achieving a better regulatory fit.
    Hoffmann DE; Fraser CM; Palumbo F; Ravel J; Rowthorn V; Schwartz J
    Food Drug Law J; 2014; 69(2):237-72, ii. PubMed ID: 25163211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The science and regulations of probiotic food and supplement product labeling.
    Sanders ME; Levy DD
    Ann N Y Acad Sci; 2011 Feb; 1219 Suppl 1():E1-E23. PubMed ID: 21332758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is my yogurt lying? Developing and applying a framework for determining whether wellness claims on probiotic yogurts mislead.
    Satine LA
    Food Drug Law J; 2008; 63(2):537-77. PubMed ID: 18561477
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: regulatory considerations in Canada, E.U., and U.S.
    Sanders ME; Tompkins T; Heimbach JT; Kolida S
    Eur J Nutr; 2005 Aug; 44(5):303-10. PubMed ID: 15338247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evidence to support health claims for probiotics.
    Farnworth ER
    J Nutr; 2008 Jun; 138(6):1250S-4S. PubMed ID: 18492865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correcting regulatory chaos: is there light at the tunnel's end?
    Marty AT
    J Altern Complement Med; 2003 Aug; 9(4):459. PubMed ID: 14499019
    [No Abstract]   [Full Text] [Related]  

  • 10. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 11. Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.
    Hibberd PL; Davidson L
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S137-40; discussion S144-51. PubMed ID: 18181720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH
    Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional foods: the Food and Drug Administration perspective.
    Ross S
    Am J Clin Nutr; 2000 Jun; 71(6 Suppl):1735S-8S; discussion 1739S-42S. PubMed ID: 10837331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary Supplements: Foods, Medicines, or Both? A Controversial Designation with Unspecific Legislation.
    Pereira C; Barros L; Ferreira ICFR
    Curr Pharm Des; 2017; 23(19):2722-2730. PubMed ID: 28124610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The end of paternalism: a new approach to food labeling.
    Steinborn SB; Todd KA
    Food Drug Law J; 1999; 54(3):401-22. PubMed ID: 11797706
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa.
    Brink M; Senekal M; Dicks LM
    S Afr Med J; 2005 Feb; 95(2):114-9. PubMed ID: 15751206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why Americans Need Information on Dietary Supplements.
    Dwyer JT; Coates PM
    J Nutr; 2018 Aug; 148(suppl_2):1401S-1405S. PubMed ID: 31505678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.